CAY10680: Unlocking the Potential for Bowel Syndrome Relief

In the complex world of gastrointestinal disorders, CAY10680 emerges as a promising compound that holds the key to addressing the debilitating symptoms of bowel syndrome. This meticulously crafted substance, identified by its CAS number 1439488-21-7, has been the subject of extensive research, revealing its remarkable ability to inhibit the underlying mechanisms that contribute to this functional gastrointestinal disorder.

Bowel syndrome, a condition characterized by chronic abdominal pain and altered bowel habits, can significantly impact an individual's quality of life. CAY10680 has demonstrated its potential to alleviate this burden, offering a glimmer of hope for those seeking relief. Through its targeted inhibition of substance P-induced hyperalgesia in the rat and colonic motility in the rabbit, this compound has shown promise in addressing the core symptoms of bowel syndrome.

Unlocking the Potential of Adenosine Receptors

Beyond its direct impact on bowel function, CAY10680 also exhibits a unique ability to bind to adenosine receptors, specifically the A2B and A2A subtypes. This interaction with the adenosine receptor system opens up new avenues for understanding and potentially treating the complex mechanisms underlying bowel syndrome. By modulating the activity of these receptors, CAY10680 may offer a multifaceted approach to managing the condition, addressing both the physical symptoms and the underlying neurological pathways involved.

The versatility of CAY10680 extends beyond its primary application in bowel syndrome. Its potential as a research tool and therapeutic candidate has captured the attention of scientists across various disciplines, from gastroenterology to neuroscience. As researchers delve deeper into the compound's mechanisms of action and explore its broader applications, the possibilities for unlocking new frontiers in medical research and treatment become increasingly exciting.

Exceptional Purity and Quality

Ensuring the highest standards of quality and purity, CAY10680 boasts a minimum purity of 95%, as indicated by its chemical information. With a molecular formula of C18H16N2O2S and a molecular weight of 324.4 g/mol, this compound is meticulously crafted to meet the rigorous demands of scientific research and development.

The Ref # 3D-PHC48821 provides a unique identifier for this product, allowing researchers to easily track and access relevant information, technical data, and safety guidelines. This level of detail and transparency is crucial in the world of specialized chemical compounds, empowering scientists to make informed decisions and navigate their research with confidence.

Unlocking New Possibilities in Bowel Syndrome Treatment

As the scientific community continues to explore the potential of CAY10680, the promise of improved treatment options for those suffering from bowel syndrome grows ever brighter. This compound's ability to modulate key physiological pathways, coupled with its exceptional purity and quality, positions it as a valuable tool in the ongoing quest to alleviate the burden of this debilitating condition.

By harnessing the power of CAY10680, researchers and clinicians can unlock new possibilities in the management of bowel syndrome, offering hope and relief to those in need. As the understanding of this compound deepens, the potential for innovative therapies and groundbreaking discoveries in the field of gastroenterology becomes increasingly tangible, paving the way for a brighter future for those affected by this challenging disorder.

• CAS Number: 1439488-21-7
• Ref #: 3D-PHC48821
• Purity: Min. 95%
• Molecular Formula: C18H16N2O2S
• Molecular Weight: 324.4 g/mol
• Description: CAY10680 is a substance that inhibits the bowel syndrome, which is a functional gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits.